Medical management of stable coronary atherosclerosis.

P. Pellicori, P. Costanzo, A. C. Joseph, A. Hoye, Stephen Atkin, J. G. Cleland

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Revascularisation strategies involving coronary artery bypass grafting or percutaneous interventions are the main treatments for stable coronary artery disease, particularly for patients with ongoing symptoms despite medical therapy and/or extensive ischaemia as demonstrated by either non-invasive or invasive means. Irrespective of whether revascularisation is being undertaken, all patients with stable coronary disease require optimal medical therapy in order to reduce the risk of subsequent adverse cardiac events, particularly acute myocardial infarction. The role of medical management has been very actively investigated and reported, particularly because of the global disease burden and the associated high morbidity and mortality. In this review, the current available medical management for the treatment of coronary atherosclerosis is described together with the role and prospects of the newer classes of drugs that are coming into use, and future perspectives in this field.

Original languageEnglish
Pages (from-to)313
Number of pages1
JournalCurrent Atherosclerosis Reports
Volume15
Issue number4
DOIs
Publication statusPublished - Apr 2013
Externally publishedYes

Fingerprint

Coronary Artery Disease
Therapeutics
Coronary Artery Bypass
Coronary Disease
Ischemia
Myocardial Infarction
Morbidity
Mortality
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Pellicori, P., Costanzo, P., Joseph, A. C., Hoye, A., Atkin, S., & Cleland, J. G. (2013). Medical management of stable coronary atherosclerosis. Current Atherosclerosis Reports, 15(4), 313. https://doi.org/10.1007/s11883-013-0313-0

Medical management of stable coronary atherosclerosis. / Pellicori, P.; Costanzo, P.; Joseph, A. C.; Hoye, A.; Atkin, Stephen; Cleland, J. G.

In: Current Atherosclerosis Reports, Vol. 15, No. 4, 04.2013, p. 313.

Research output: Contribution to journalReview article

Pellicori, P, Costanzo, P, Joseph, AC, Hoye, A, Atkin, S & Cleland, JG 2013, 'Medical management of stable coronary atherosclerosis.', Current Atherosclerosis Reports, vol. 15, no. 4, pp. 313. https://doi.org/10.1007/s11883-013-0313-0
Pellicori, P. ; Costanzo, P. ; Joseph, A. C. ; Hoye, A. ; Atkin, Stephen ; Cleland, J. G. / Medical management of stable coronary atherosclerosis. In: Current Atherosclerosis Reports. 2013 ; Vol. 15, No. 4. pp. 313.
@article{e2ada0b3359540b0b0b231f7613ce460,
title = "Medical management of stable coronary atherosclerosis.",
abstract = "Revascularisation strategies involving coronary artery bypass grafting or percutaneous interventions are the main treatments for stable coronary artery disease, particularly for patients with ongoing symptoms despite medical therapy and/or extensive ischaemia as demonstrated by either non-invasive or invasive means. Irrespective of whether revascularisation is being undertaken, all patients with stable coronary disease require optimal medical therapy in order to reduce the risk of subsequent adverse cardiac events, particularly acute myocardial infarction. The role of medical management has been very actively investigated and reported, particularly because of the global disease burden and the associated high morbidity and mortality. In this review, the current available medical management for the treatment of coronary atherosclerosis is described together with the role and prospects of the newer classes of drugs that are coming into use, and future perspectives in this field.",
author = "P. Pellicori and P. Costanzo and Joseph, {A. C.} and A. Hoye and Stephen Atkin and Cleland, {J. G.}",
year = "2013",
month = "4",
doi = "10.1007/s11883-013-0313-0",
language = "English",
volume = "15",
pages = "313",
journal = "Current Atherosclerosis Reports",
issn = "1523-3804",
publisher = "Current Medicine Group",
number = "4",

}

TY - JOUR

T1 - Medical management of stable coronary atherosclerosis.

AU - Pellicori, P.

AU - Costanzo, P.

AU - Joseph, A. C.

AU - Hoye, A.

AU - Atkin, Stephen

AU - Cleland, J. G.

PY - 2013/4

Y1 - 2013/4

N2 - Revascularisation strategies involving coronary artery bypass grafting or percutaneous interventions are the main treatments for stable coronary artery disease, particularly for patients with ongoing symptoms despite medical therapy and/or extensive ischaemia as demonstrated by either non-invasive or invasive means. Irrespective of whether revascularisation is being undertaken, all patients with stable coronary disease require optimal medical therapy in order to reduce the risk of subsequent adverse cardiac events, particularly acute myocardial infarction. The role of medical management has been very actively investigated and reported, particularly because of the global disease burden and the associated high morbidity and mortality. In this review, the current available medical management for the treatment of coronary atherosclerosis is described together with the role and prospects of the newer classes of drugs that are coming into use, and future perspectives in this field.

AB - Revascularisation strategies involving coronary artery bypass grafting or percutaneous interventions are the main treatments for stable coronary artery disease, particularly for patients with ongoing symptoms despite medical therapy and/or extensive ischaemia as demonstrated by either non-invasive or invasive means. Irrespective of whether revascularisation is being undertaken, all patients with stable coronary disease require optimal medical therapy in order to reduce the risk of subsequent adverse cardiac events, particularly acute myocardial infarction. The role of medical management has been very actively investigated and reported, particularly because of the global disease burden and the associated high morbidity and mortality. In this review, the current available medical management for the treatment of coronary atherosclerosis is described together with the role and prospects of the newer classes of drugs that are coming into use, and future perspectives in this field.

UR - http://www.scopus.com/inward/record.url?scp=84881229107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881229107&partnerID=8YFLogxK

U2 - 10.1007/s11883-013-0313-0

DO - 10.1007/s11883-013-0313-0

M3 - Review article

VL - 15

SP - 313

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

SN - 1523-3804

IS - 4

ER -